Diagnostic accuracy of early biomarkers for acute coronary syndrome (ACS) (2012) CarrollChristopher GoodacreStephen StevensJohn LeavissJoanna 2020 <p>Background: Current practice for suspected ACS involves troponin testing 10-12 hours after symptom onset to diagnose myocardial infarction (MI).</p> <p>Aim: To estimate the diagnostic accuracy of early biomarkers for MI to determine if an earlier, accurate decision was possible<br></p> <p>Rationale: Early discharge of patients with no or low risk of ACS will result in cost savings and reduced healthcare and patient burden.</p>